Contact Us
Contact Us
Home Finance Oppenheimer raises Revolution stock price target on FDA approval
Finance

Oppenheimer raises Revolution stock price target on FDA approval

August 26, 20261 Mins read1
Share
Oppenheimer raises Revolution stock price target on FDA approval
Share


Oppenheimer raises Revolution stock price target on FDA approval

Source link

Share
Raymond James declares alt= Previous post Raymond James declares $0.54 quarterly dividend

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Viemed at Midwest IDEAS: growth, cash flow and a wider runway
Finance

Viemed at Midwest IDEAS: growth, cash flow and a wider runway

ByAugust 26, 2026
Ani Pharmaceuticals CEO sells 1,220 in company stock
Finance

Ani Pharmaceuticals CEO sells $401,220 in company stock

ByAugust 26, 2026
Earnings call transcript: Salesforce tops Q2 2026 profit forecasts, shares jump
Finance

Earnings call transcript: Salesforce tops Q2 2026 profit forecasts, shares jump

ByAugust 26, 2026
Earnings call transcript: Agilent tops Q3 2026 estimates, lifts outlook
Finance

Rainier Acquisition prices $75M IPO on Nasdaq

ByAugust 26, 2026
© Copyright 2024 Jellywp. All rights reserved powered by Jellywp.com